The pandemic and the pharmaceutical world
14
“Are pandemics an opportunity for growth or a source of decline in the pharmaceutical world?”
This is the question that plagues the minds of those working in the pharma industry. Looking back at previous pandemics, namely the black death (1346-1353), flu (1889-1890, 1918 and 1968), sixth cholera (1910-1911), Asian flu (1956-1958) and HIV-AIDs (2005-2012), many industries were affected negatively, individuals had complete upheaval in their daily activities, millions died and the pharmaceutical world was hugely affected. The current pandemic – the novel coronavirus disease 2019 (COVID-19), spanning from 2019 to date – is no exception.
The overall financial gains likely brought by the pandemic and the funding that has been fed into pandemic-related research means COVID-19 has primarily been a source of growth”